• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    29.78 Up 0.48(1.64%) Mar 5, 4:00PM EST
    |Pre-Market : 29.51 7:25PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 1,477   1,101   592   416  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,477   1,101   592   416  
    Operating Expenses
    Research Development27,026  26,186  24,099  27,070  
    Selling General and Administrative6,249  5,004  4,787  4,582  
    Non Recurring -   -   -   -  
    Others253  253  254  253  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (32,051) (30,342) (28,548) (31,489)
    Income from Continuing Operations
    Total Other Income/Expenses Net229  2,261  274  1,586  
    Earnings Before Interest And Taxes(31,822)(28,081)(28,274)(29,903)
    Interest Expense -   -   -   -  
    Income Before Tax(31,822)(28,081)(28,274)(29,903)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(31,822)(28,081)(28,274)(29,903)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (31,822) (28,081) (28,274) (29,903)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (31,822) (28,081) (28,274) (29,903)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.